Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseases.
Latest Information Update: 31 May 2022
At a glance
- Drugs Immune globulin (Primary)
- Indications Bacterial infections; Primary immunodeficiency diseases
- Focus Therapeutic Use
- Sponsors Octapharma
Most Recent Events
- 17 Nov 2009 New trial record